Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Camillo Ribi

Showing results (101-110 of 124) with videos related to

Pageof 13
Sort By:
Arthritis and Rheumatism|February 5, 2010
Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patientsCamillo Ribi, Pascal Cohen, Christian Pagnoux, et al.
Frontiers in Allergy|October 14, 2022
Intradermal Testing With COVID-19 mRNA Vaccines Predicts ToleranceFlorian Stehlin, Rima Mahdi-Aljedani, Loris Canton, et al.
BMC Nephrology|November 23, 2019
Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritisJusta Friebus-Kardash, Marten Trendelenburg, Ute Eisenberger, et al.
Rheumatology (Oxford, England)|January 24, 2020
Corrigendum to: Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study GroupAntoine Lafarge, Adrien Joseph, Christian Pagnoux, et al.
Annals of the Rheumatic Diseases|November 27, 2019
Risk of malignancy in patients treated for systemic necrotising vasculitisAntoine Lafarge, Adrien Joseph, Christian Pagnoux, et al.
Rheumatology (Oxford, England)|November 30, 2019
Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study GroupAntoine Lafarge, Adrien Joseph, Christian Pagnoux, et al.
Arthritis and Rheumatism|March 9, 2011
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyCem Gabay, Michael Bel, Christophe Combescure, et al.
Revue Medicale Suisse|May 22, 2026
[Cardiac sarcoidosis in 2026 : current perspectives]Aarthiga Sritharan, Christel Hermann Kamani, Henri Lu, et al.
Rheumatology (Oxford, England)|September 29, 2018
Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosusAnne-Katrin Pröbstel, Madlaina Thanei, Barbara Erni, et al.
Communications Medicine|November 30, 2024
Features of chronic urticaria after COVID-19 mRNA vaccine over timeJohan Schwab, Mathilde Foglierini, Eva Pescosolido, et al.
Pageof 13

Showing results (101-110 of 124) with videos related to

Sort By:
Pageof 13
Arthritis and Rheumatism|February 5, 2010
Treatment of polyarteritis nodosa and microscopic polyangiitis without poor-prognosis factors: A prospective randomized study of one hundred twenty-four patientsCamillo Ribi, Pascal Cohen, Christian Pagnoux, et al.
Frontiers in Allergy|October 14, 2022
Intradermal Testing With COVID-19 mRNA Vaccines Predicts ToleranceFlorian Stehlin, Rima Mahdi-Aljedani, Loris Canton, et al.
BMC Nephrology|November 23, 2019
Susceptibility of BAFF-var allele carriers to severe SLE with occurrence of lupus nephritisJusta Friebus-Kardash, Marten Trendelenburg, Ute Eisenberger, et al.
Rheumatology (Oxford, England)|January 24, 2020
Corrigendum to: Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study GroupAntoine Lafarge, Adrien Joseph, Christian Pagnoux, et al.
Annals of the Rheumatic Diseases|November 27, 2019
Risk of malignancy in patients treated for systemic necrotising vasculitisAntoine Lafarge, Adrien Joseph, Christian Pagnoux, et al.
Rheumatology (Oxford, England)|November 30, 2019
Predictive factors of severe infections in patients with systemic necrotizing vasculitides: data from 733 patients enrolled in five randomized controlled trials of the French Vasculitis Study GroupAntoine Lafarge, Adrien Joseph, Christian Pagnoux, et al.
Arthritis and Rheumatism|March 9, 2011
Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center studyCem Gabay, Michael Bel, Christophe Combescure, et al.
Revue Medicale Suisse|May 22, 2026
[Cardiac sarcoidosis in 2026 : current perspectives]Aarthiga Sritharan, Christel Hermann Kamani, Henri Lu, et al.
Rheumatology (Oxford, England)|September 29, 2018
Association of antibodies against myelin and neuronal antigens with neuroinflammation in systemic lupus erythematosusAnne-Katrin Pröbstel, Madlaina Thanei, Barbara Erni, et al.
Communications Medicine|November 30, 2024
Features of chronic urticaria after COVID-19 mRNA vaccine over timeJohan Schwab, Mathilde Foglierini, Eva Pescosolido, et al.
Pageof 13